Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$267,991
+$6,789 QoQ
Shares Held
1,710
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#1,188
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bravera Wealth holds $2,269,977 across 8 Drug Manufacturers - General names. NVS ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,845 | $722,544 | |
| 2 | ABBV |
AbbVie Inc.
|
2,446 | $615,511 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,860 | $496,010 | |
| 4 | NVS |
Novartis AG
This page
|
1,710 | $267,991 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,825 | $105,156 | |
| 6 | LLY |
ELI LILLY & Co
|
28 | $33,584 | |
| 7 | PFE |
Pfizer Inc
|
971 | $23,381 | |
| 8 | NVO |
Novo Nordisk A S
|
121 | $5,800 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,991 | 1,710 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $261,202 | 1,710 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $239,066 | 1,734 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||